ライフサイエンスコーパス: transcutaneous

1 the most relevant (e.g. inhaled vs. oral vs. transcutaneous).

2 film has strength in shear of 61 N/cm(2) and transcutaneous adhesive strength of 511 N/cm(2), generat

3 at 2 years of age, supporting the concept of transcutaneous allergen sensitization, even in infants w

4 is typically provided by externally powered transcutaneous amperometric sensors.

5 red transdiaphragmatic pressure (Pdi) during transcutaneous and cervical magnetic stimulation of the

6 red with transcutaneous stimulation, and (2) transcutaneous and cervical magnetic twitch Pdi are affe

7 to-beat blood pressure (BP), heart rate, and transcutaneous and end-tidal CO(2) concentrations.

8 CBFV and transcutaneous and end-tidal CO(2) levels declined signi

9 The ratios of the transcutaneous and ex vivo radioactive SLN count to the

10 least 10 twitches were obtained during both transcutaneous and magnetic stimulation before and 10, 3

11 dyes, wherefore the signals can be read out transcutaneous and non-invasively with a custom-built ph

12 t high or very high risk of cardiac surgery, transcutaneous aortic valve implantation is an increasin

13 the mainstay of therapy for aortic stenosis, transcutaneous aortic valve implantation options are evo

14 A total of 12 of the 24 dogs had concomitant transcutaneous application of low-frequency ultrasound (

15 crease in Th2-associated cytokine secretion, transcutaneous application revealed a general downregula

16 comparison between the transconjunctival and transcutaneous approaches was also assessed.

17 ese results, supports further examination of transcutaneous arginase inhibition as a therapeutic moda

18 dy demonstrates the therapeutic potential of transcutaneous arginase inhibition in cSCC.

19 tual threshold cervical implanted (iVNS) and transcutaneous auricular (taVNS) vagus nerve stimulation

20 first systematic review and meta-analysis of transcutaneous auricular stimulation safety.

21 Given the anti-inflammatory effect of transcutaneous auricular vagus nerve stimulation (taVNS)

22 e safety and efficacy of nightly, bilateral, transcutaneous auricular vagus nerve stimulation (taVNS)

23 The efficacy of transcutaneous auricular vagus nerve stimulation (taVNS)

24 in humans, we applied continuous noninvasive transcutaneous auricular vagus nerve stimulation (taVNS)

25 Transcutaneous auricular vagus nerve stimulation (taVNS)

26 Transcutaneous auricular vagus nerve stimulation (taVNS)

27 Transcutaneous auricular vagus nerve stimulation (taVNS)

28 Transcutaneous auricular vagus nerve stimulation (taVNS)

29 Transcutaneous auricular vagus nerve stimulation (taVNS)

30 Transcutaneous auricular vagus nerve stimulation (taVNS)

31 We therefore compared the effects of transcutaneous auricular vagus nerve stimulation (taVNS,

32 the current study, we show that noninvasive transcutaneous auricular VN stimulation enhances recolle

33 nemia, although refinement and validation of transcutaneous bilirubin nomograms are needed.

34 Transcutaneous bilirubinometry has emerged as a noninvas

35 The role of transcutaneous bilirubinometry remains promising, althou

36 Transluminal or transcutaneous biopsies for diagnosing GIST do not signi

37 did not have a biopsy (18%), 70 underwent a transcutaneous biopsy (31%), and 116 a transluminal biop

38 d DSS were both significantly shorter in the transcutaneous biopsy group on univariate analysis compa

39 The risk of needle tract seeding after transcutaneous biopsy was low.

40 From the 70 patients with a transcutaneous biopsy, only 1 patient developed a needle

41 Here, the design and testing of a modular transcutaneous biphasic (BP) cell delivery device that p

42 calculated within 30 minutes from LUS, using transcutaneous blood gas monitoring.

43 Using transcutaneous blood glucose detection as an example, we

44 Nine transcutaneous bowel wall SWV measurements were obtained

45 Heart rate and transcutaneous carbon dioxide tension were higher in the

46 lse oximetry, transcutaneous oxygen tension, transcutaneous carbon dioxide tension, and mean arterial

47 esaturation, low transcutaneous oxygen, high transcutaneous carbon dioxide tensions, low oxygen deliv

48 ductive plethysmography), oxygen saturation, transcutaneous carbon dioxide, and indicators of lung me

49 Transcutaneous carbon dioxide, tidal volume, and minute

50 Under ultrasound guidance, after direct transcutaneous carotid puncture with a 24-gauge needle,

51 uses very low temperatures to destroy cells; transcutaneous cryoablation can be performed under imagi

52 In certain situations, rapid transcutaneous delivery is very desirable.

53 a worldwide problem that may be addressed by transcutaneous delivery of a vaccine.

54 ndertook an initial investigation of whether transcutaneous delivery of an endogenous anti-inflammato

55 strongly that AFL is safe and sufficient for transcutaneous delivery of drugs and vaccines.

56 mposed by the stratum corneum and facilitate transcutaneous delivery of nanoparticle delivery systems

57 posed sonicated dextrose albumin (PESDA) and transcutaneous delivery of ultrasound alone.

58 Transcutaneous delivery of vaccines using microneedles h

59 ility of plant oils might offer alternative, transcutaneous delivery routes.

60 it vaccine on Microneedle Arrays (PSMNs) for transcutaneous delivery using layer-by-layer (LbL) assem

61 n disorders required reformulation to enable transcutaneous delivery.

62 lly, electrically, or through a non-invasive transcutaneous device attenuate CAC progression, allevia

63 We employed i) a transcutaneous device that measures the half-life of int

64 Transcutaneous DNA immunization by modifying the hair fo

65 of enhancing the immune responses induced by transcutaneous DNA immunization following 'warm' waxing-

66 Transcutaneous DNA immunization is an attractive immuniz

67 The antibody response induced by transcutaneous DNA immunization was hair cycle dependent

68 AFL was superior to tape stripping in transcutaneous drug and vaccine delivery as a much highe

69 Transcutaneous drug delivery has been the subject of int

70 in disorders, skin health and wound healing, transcutaneous drug delivery, and bioelectronic medicine

71 ently disrupt stratum corneum and facilitate transcutaneous drug delivery, but it is frequently assoc

72 These are however, limitable with the aid of transcutaneous drug delivery.

73 e procedure and after balloon dilation using transcutaneous duplex US.

74 of 20 (40%), respectively) were activated by transcutaneous electrical and thermal stimuli.

75 The interventions were high-frequency transcutaneous electrical nerve stimulation (TENS) and a

76 that treatment with peripheral low-frequency transcutaneous electrical nerve stimulation (TENS) appli

77 This study investigated the effect of Transcutaneous Electrical Nerve Stimulation (TENS) for f

78 Transcutaneous electrical nerve stimulation (TENS) is a

79 sensations can be elicited through targeted transcutaneous electrical nerve stimulation (tTENS) in i

80 The active control group (n = 105) received transcutaneous electrical nerve stimulation and active r

81 ompared with an active control that included transcutaneous electrical nerve stimulation and active r

82 meta-analysis for pain reduction showed that transcutaneous electrical nerve stimulation combined wit

83 odulation system) or sham stimulation (via a transcutaneous electrical nerve stimulation machine to t

84 pain and improve physical function, or with transcutaneous electrical nerve stimulation to reduce pa

85 twave diathermy, superficial heat, traction, transcutaneous electrical nerve stimulation, and ultraso

86 or in combination with other interventions), transcutaneous electrical nerve stimulation, gabapentin,

87 For transcutaneous electrical nerve stimulation, there is lo

88 transcranial direct current stimulation, and transcutaneous electrical nerve stimulation.

89 lking aids and splints, manual therapies and transcutaneous electrical nerve stimulation.

90 To determine whether training combined with transcutaneous electrical spinal cord stimulation (tSCS)

91 skill learning process by applying cervical transcutaneous electrical spinal stimulation (TESS) to i

92 nflammatory effects of noninvasive low-level transcutaneous electrical stimulation (LLTS) of the grea

93 l sphincter (EUS) dysfunction, and assess if transcutaneous electrical stimulation (TENS) of the dors

94 nin-induced synovial plasma extravasation by transcutaneous electrical stimulation at strengths which

95 Although transcutaneous electrical stimulation devices have prove

96 , 8 treatments with acupuncture or with mock transcutaneous electrical stimulation of acupuncture poi

97 ditory and non-auditory structures following transcutaneous electrical stimulation of the basal part

98 We show that non-invasive transcutaneous electrical stimulation of the greater occ

99 ing number of studies supports the view that transcutaneous electrical stimulation of the spinal cord

100 Accumulating evidence supports the view that transcutaneous electrical stimulation of the spinal cord

101 we develop a microneedle-based self-powered transcutaneous electrical stimulation system (mn-STESS)

102 finger sliding into electricity and mediates transcutaneous electrical stimulation through microneedl

103 Transcutaneous electrical stimulation was applied onto t

104 olol, and nonpharmacologic approaches (e.g., transcutaneous electrical stimulation) as parts of multi

105 eflexes from specific muscles elicited using transcutaneous electrical stimulation.

106 nger afterdischarges and abnormal wind-up to transcutaneous electrical stimuli.

107 eripheral neurons activated electrically via transcutaneous electrodes and ethologically with von Fre

108 carpine and oral cevimeline, acupuncture, or transcutaneous electrostimulation may be offered after r

109 Transcutaneous epicardial mapping was performed in a con

110 l, subcutaneous, intravenous, intramuscular, transcutaneous, etc.

111 Transcutaneous excision of WGDCs has proven to be an eff

112 Transcutaneous exposure of the cervical lymph nodes to v

113 Transcutaneous exposure to food allergens can lead to fo

114 ose is determined continuously in vivo using transcutaneous, fiber-based mid-infrared laser spectrosc

115 1 diabetes, as assessed by in vivo real-time transcutaneous fluorescence, confocal microscopy, and el

116 bronchospasm in asthmatics and it comes in a transcutaneous form that can be used in patients who are

117 Together, these results demonstrate that transcutaneous FUS drives peripheral nerve activity by e

118 he latest progress on quantitative, in vivo, transcutaneous glucose sensing using surface enhanced sp

119 rates of both transepidermal water loss and transcutaneous heat loss, and have difficulty maintainin

120 low-up data from the Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme.

121 Furthermore, this transcutaneous IL-10 gene therapy decreased signs of ski

122 ols to perform tasks on the basis of medical transcutaneous imaging, in a less invasive way, at lower

123 c electronic randomisation system to receive transcutaneous immunisation with a patch containing 37.5

124 with recombinant protective antigen (rPA) by transcutaneous immunization (TCI) induced long-term neut

125 Transcutaneous immunization (TCI) is a needle-free techn

126 Transcutaneous immunization (TCI) is a new method for va

127 Transcutaneous immunization (TCI) is a new technique tha

128 In this set of animal studies, transcutaneous immunization (TCI) using recombinant colo

129 Transcutaneous immunization (TCI), the application of va

130 Transcutaneous immunization allows safe delivery of nati

131 of cholera toxin (CT) to the skin results in transcutaneous immunization and induces a systemic Ab re

132 Previously, we reported that transcutaneous immunization by applying plasmid DNA onto

133 showed that the immune responses induced by transcutaneous immunization by applying plasmid DNA onto

134 on devices, and skin delivery techniques for transcutaneous immunization demonstrate that adjuvant sy

135 immune response through microneedle-mediated transcutaneous immunization may be attributed to their a

136 Transcutaneous immunization of mice with recombinant pro

137 djuvant dmLT and delivered via a noninvasive transcutaneous immunization route induced an immune resp

138 nses as intramuscular injection of them, but transcutaneous immunization was able to induce specific

139 Our results suggest that transcutaneous immunization with CDA toxoid may be a fea

140 Transcutaneous immunization with CT induced prominent Ig

141 To evaluate whether transcutaneous immunization with formalin-treated C. dif

142 usly, it was shown that microneedle-mediated transcutaneous immunization with plasmid DNA can potenti

143 Transcutaneous immunization with plasmid DNA-coated net

144 Transcutaneous immunization with plasmid DNA-coated net

145 Our results suggest that transcutaneous immunization with TcpA and an immunoadjuv

146 Transcutaneous immunization, a topical vaccine applicati

147 scribed a needle-free method of vaccination, transcutaneous immunization, consisting of the topical a

148 Transcutaneous immunotherapy via laser microporation is

149 udy was performed to compare the efficacy of transcutaneous immunotherapy via laser-generated micropo

150 sts via the respiratory route, but traumatic transcutaneous implantation is also an important source

151 g reduced virus-specific immune memory after transcutaneous infection with a live virus.

152 Tumors were generated by transcutaneous injection of 5 X 10(5) murine squamous ca

153 n 16 subjects, the ISLN was anaesthetised by transcutaneous injection of bupivacaine into the paraglo

154 Transcutaneous injection through smaller hollow-bore nee

155 ejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS)

156 ejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS)

157 epatocyte transplantation method involving a transcutaneous, intrahepatic injection in neonatal mice.

158 al to remain at the site of injection, until transcutaneous irradiation breaks the link between polym

159 Transcutaneous laryngeal ultrasonography (TLUS) has beco

160 After ultrasound-guided transcutaneous liver drainage, both abscess fluids and b

161 aluated the coronary vasodilatory effects of transcutaneous low-frequency (27-kHz) ultrasound (USD).

162 aluated the potential vasodilator effects of transcutaneous low-frequency ultrasound (US) in human br

163 first study to demonstrate that noninvasive transcutaneous low-frequency US energy dilates human bra

164 Transcutaneous low-level tragus electrical stimulation (

165 Transcutaneous magnetic stimulation (TcMS) can noninvasi

166 therapy treated with left stellate ganglion transcutaneous magnetic stimulation (TCMS) to reduce car

167 Transcutaneous magnetic stimulation (TMS) applied to the

168 Transcutaneous magnetic stimulation (TMS) may provide a

169 s could ascertain mucosal integrity, because transcutaneous measurement of differentially absorbed mo

170 The Rotarex transcutaneous mechanical thrombectomy system is an effi

171 Here we developed a method of transcutaneous mechanical vagus nerve stimulation and th

172 Pulse oximetry (SpO2) is routinely used for transcutaneous monitoring of blood oxygenation, but it c

173 Transcutaneous monitoring was done simultaneous with art

174 imulation of an amputee's phantom limb using transcutaneous nerve stimulation (TENS).

175 nistered intraoperatively and assessed using transcutaneous NIR.

176 were then randomized to receive electrical, transcutaneous, or sham vagus nerve stimulation and were

177 es bacterial colonization of the stoma after transcutaneous osseointegrated prosthetic systems surger

178 Transcutaneous osseointegration post amputation (TOPA) c

179 Transcutaneous osseointegration post amputation, consist

180 However, noninvasive transcutaneous oxygen (PtcO2) and carbon dioxide (PtcCO2

181 ial pressure to measure cardiac function and transcutaneous oxygen (PtcO2) to reflect tissue perfusio

182 ximetry to screen for pulmonary problems; c) transcutaneous oxygen and carbon dioxide tension sensors

183 od pressure, heart rate, pulse oximetry, and transcutaneous oxygen and carbon dioxide tensions beginn

184 es: spatial frequency domain imaging (SFDI), transcutaneous oxygen measurement (TCOM), wearable photo

185 walking distance, ankle-brachial index, and transcutaneous oxygen measurements (all P < 0.00001).

186 g or a toe pressure <50 mm Hg, or both, or a transcutaneous oxygen pressure <30 mm Hg on the treated

187 of methacholine producing a 15% decrease in transcutaneous oxygen pressure [PD(15)]) at age 1 month

188 ith neuroischemic ulcers and toe pressure or transcutaneous oxygen pressure between 30 and 59 mm Hg w

189 f life, rest pain, ankle-brachial index, and transcutaneous oxygen pressure improved during follow-up

190 Mean toe pressure was 46.1 mm Hg, and transcutaneous oxygen pressure was 49.8 mm Hg.

191 method comprises a small, low-energy optical transcutaneous oxygen sensor applied on the flap's skin

192 ety and limb tissue perfusion as measured by transcutaneous oxygen tension (TcPo(2)) in patients with

193 alues (cardiac index >4.5 L/min/m2, ratio of transcutaneous oxygen tension to fractional inspired oxy

194 ly increased ankle brachial index, increased transcutaneous oxygen tension, and reduced rest pain.

195 higher oxygen delivery, oxygen consumption, transcutaneous oxygen tension, and transcutaneous oxygen

196 timated the changes in ankle brachial index, transcutaneous oxygen tension, rest pain, and walking ca

197 The cardiac index, pulse oximetry, transcutaneous oxygen tension, transcutaneous carbon dio

198 sumption, transcutaneous oxygen tension, and transcutaneous oxygen tension/FIO2 ratios, than did the

199 index, arterial hemoglobin desaturation, low transcutaneous oxygen, high transcutaneous carbon dioxid

200 The transcutaneous partial pressure of oxygen (Ptco2) to fra

201 ls for human skin, widely used to probe drug transcutaneous passage and to test new skin vaccination

202 significant differences in isotime VD/VT or transcutaneous Pco(2) among treatments.

203 ion, surface inspiratory muscle EMG, Spo(2), transcutaneous Pco(2), and Borg dyspnea scores.

204 Mean cerebral tissue oxygenation and mean transcutaneous PCO2 values were reduced but failed to re

205 nd perirenal tissue oxygenation, heart rate, transcutaneous PCO2, and tidal volume were simultaneousl

206 surements, Pdi was measured during bilateral transcutaneous phrenic nerve stimulation at 10 Hz in fou

207 this study was to assess the feasibility of transcutaneous phrenic nerve stimulation, used in conjun

208 he diaphragm was stimulated with a prototype transcutaneous phrenic nerve stimulator at a rate of ten

209 Transcutaneous Po2 increased over time in both groups, w

210 Two different pulse oximeters and a transcutaneous PO2 monitor were used to record the data

211 ection-enhanced delivery via a skull-mounted transcutaneous port as a novel administration paradigm t

212 n with pulse palpation (43%, CI 36%-50%) and transcutaneous pressure of oxygen (31%, CI 24%-38%).

213 (ABPI), toe-brachial pressure index (TBPI), transcutaneous pressure of oxygen (TcPO2), pulse palpati

214 pressure index, audible and visual Doppler, transcutaneous pressure of oxygen, and pulse palpation.

215 pressure index, toe-brachial pressure index, transcutaneous pressure of oxygen, pulse palpation, and

216 Although transcutaneous quantification of jaundice may help disce

217 man spectroscopy, particularly as applied to transcutaneous Raman spectroscopy measurements, is overc

218 Mice immunized with CT by the transcutaneous route exhibited significant protection fr

219 vaccination of patients with AD through the transcutaneous route revealed that high baseline IgE lev

220 Mice immunized by the transcutaneous route with tetanus fragment C and CT deve

221 ted mucosal disease when administered by the transcutaneous route.

222 osal toxin challenge can be achieved via the transcutaneous route.

223 ion to infant skin could potentially promote transcutaneous sensitization and the development of food

224 othesis that peanut allergy develops through transcutaneous sensitization in children with an impaire

225 Food allergy is thought to develop through transcutaneous sensitization, especially in the presence

226 mote the development of food allergy through transcutaneous sensitization.

227 We also tested the ability of transcutaneous sensors to measure the ratios of absorbed

228 lly, the fourth dataset pertained to invivo, transcutaneous spectra obtained from healthy volunteers

229 Transcutaneous spinal cord stimulation (tSCS) has become

230 Transcutaneous spinal cord stimulation (tSCS) has shown

231 e antidepressant effects and tolerability of transcutaneous spinal direct current stimulation (tsDCS)

232 tions have recently addressed the effects of transcutaneous spinal Direct Current Stimulation (tsDCS)

233 ent studies have investigated the effects of transcutaneous spinal direct current stimulation (tsDCS)

234 ectrical nerve stimulation (TENS) and anodal transcutaneous spinal direct current stimulation (tsDCS)

235 long-lasting effects of a single session of transcutaneous spinal direct current stimulation (tsDCS)

236 Transcutaneous spinal stimulation (scTS), also capable o

237 Transcutaneous spinal stimulation enables trunk stabilit

238 75634) determined the safety and efficacy of transcutaneous spinal stimulation to enable upright sitt

239 s obtained during both cervical magnetic and transcutaneous stimulation before and 2, 10, and 30 min

240 echnique may differ from those obtained with transcutaneous stimulation in individual subjects.

241 volunteers evaluated the effect of bilateral transcutaneous stimulation of vagal auricular innervatio

242 It has recently been shown that low-level, transcutaneous stimulation of vagus nerve at the tragus

243 ver, the most commonly employed methodology (transcutaneous stimulation) is technically difficult.

244 rger with magnetic stimulation compared with transcutaneous stimulation, and (2) transcutaneous and c

245 t least a 10% reduction in twitch Pdi during transcutaneous stimulation, while all 10 subjects had a

246 y obviate some of the problems inherent with transcutaneous stimulation.

247 eater for magnetic stimulation compared with transcutaneous stimulation: 21.0 +/- 3.1 versus 7.8 +/-

248 er during magnetic stimulation compared with transcutaneous stimulation: 39.3 +/- 3.0 (mean +/- SE) v

249 PdiT produced by bilateral transcutaneous supramaximal electrophrenic stimulation w

250 pressure (Pdi) was measured during bilateral transcutaneous supramaximal phrenic nerve stimulation an

251 or pollicis twitch force was measured during transcutaneous supramaximal ulnar nerve stimulation and

252 or pollicis twitch force was measured during transcutaneous supramaximal ulnar nerve stimulation befo

253 We have developed a transcutaneous (t.c.) Abeta vaccination approach and eva

254 biomarkers of immune response quality after transcutaneous (t.c.), intradermal (i.d.), and intramusc

255 Targeting of different tissues via transcutaneous (TC), intradermal (ID) and intramuscular

256 tionally, percutaneous tibial, intravaginal, transcutaneous tibial, and trans-sacral stimulations imp

257 Mean transcutaneous twitch Pdi fell only slightly from 27.4 +

258 hreshold loading, a significant reduction in transcutaneous twitch Pdi was seen in only three of the

259 For the group, transcutaneous twitch Pdi was significantly decreased fr

260 Transcutaneous UEI normalized strain also differentiated

261 Transcutaneous UEI normalized strain was able to differe

262 neuromuscular blockade were measured, using transcutaneous ulnar nerve stimulation and an accelerome

263 Bioluminescent optical imaging and transcutaneous ultrasonographic imaging were used to obs

264 nal and external openings, and length) using transcutaneous ultrasound (TCUS) imaging.

265 We hypothesized that transcutaneous ultrasound could augment thrombolysis in

266 e achieved with intravenous microbubbles and transcutaneous ultrasound delivery alone.

267 Transcutaneous ultrasound elasticity imaging (UEI) is a

268 In vivo transcutaneous ultrasound significantly augments lysis o

269 We evaluated the use of noninvasive transcutaneous ultrasound to augment coronary thrombolys

270 ies in 10 rabbits were randomized to receive transcutaneous ultrasound treatment or no ultrasound tre

271 f 17 iliofemoral arteries (59%) treated with transcutaneous ultrasound were widely patent angiographi

272 ) and magnetic resonance enterography (MRE), transcutaneous ultrasound, and PET-based imaging, has em

273 D after standard subcutaneous inoculation or transcutaneous vaccination administered with a bifurcate

274 resulted in higher seroconversion rates than transcutaneous vaccination but elicited similar antivira

275 After transcutaneous vaccination, both groups mounted similar

276 Low-level transcutaneous vagus nerve stimulation (LLTS) suppresses

277 at autonomic neuromodulation by non-invasive transcutaneous vagus nerve stimulation (tVNS) can improv

278 Transcutaneous vagus nerve stimulation (tVNS) has been p

279 Transcutaneous vagus nerve stimulation (tVNS) is a promi

280 ith preserved ejection fraction (HFpEF) that transcutaneous vagus nerve stimulation (tVNS) reduced ca

281 Noninvasive, transcutaneous vagus nerve stimulation (VNS) is currentl

282 Transcutaneous vagus nerve stimulation dose-dependently

283 Treatment with transcutaneous vagus nerve stimulation inhibited HMGB1 l

284 Transcutaneous vagus nerve stimulation is an efficacious

285 ) and electrical nerve (galvanic vestibular, transcutaneous vagus nerve, and median nerve) stimulatio

286 All patients underwent TAVR with the SAPIEN transcutaneous valve.

287 Noninvasive transcutaneous VNS (tVNS) uses electrical stimulation th

288 Here, we investigated whether transcutaneous VNS improves sensory performance in human

289 typical adults, that measured the effects of transcutaneous VNS on metrics of auditory and visual per

290 We hypothesize that using transcutaneous VNS via the auricular afferent branch cou

291 by the Na(+)-dependent, internally positive transcutaneous voltage of the intact skin of the limb st

292 ry, barrier function (through restriction of transcutaneous water movement) could regulate the format

293 visualised externally by use of quantitative transcutaneous whole-body fluorescence imaging.